MNOV

MediciNova, Inc. NASDAQ Listed Dec 8, 2006

Healthcare ·Biotechnology ·US · medicinova.com

$1.43

Mkt Cap $70.4M

52w Low $1.17 32.9% of range 52w High $1.96

50d MA $1.42 200d MA $1.41

P/E (TTM) -5.8x

EV/EBITDA -2.8x

P/B 1.6x

Debt/Equity 0.0x

ROE -28.8%

P/FCF -6.6x

RSI (14) —

ATR (14) —

Beta 0.61

50d MA $1.42

200d MA $1.41

Avg Volume 53.5K

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction. Its product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, including nonalcoholic steatohepatitis and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. The company has collaboration agreements with Kissei Pharmaceutical Co., Ltd.; Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals Ltd.; and Meiji Seika Kaisha Ltd. MediciNova, Inc. was incorporated in 2000 and is headquartered in La Jolla, California.

SIC Code

2834

CIK (SEC)

1226616

Phone

858 373 1500

4275 Executive Square · La Jolla, CA 92037 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 20, 2026	AMC	-0.10	-0.05	+47.4%	1.50	-2.0%	-0.7%	-9.4%	+9.6%	+2.7%	-4.6%	—
Nov 12, 2025	AMC	-0.08	-0.06	+25.0%	1.57	-2.5%	-1.9%	+0.6%	-9.0%	+2.1%	-0.7%	—
Aug 14, 2025	AMC	-0.07	-0.07	+0.0%	1.30	-1.5%	+0.8%	+0.0%	-0.8%	+0.8%	-1.5%	—
May 13, 2025	AMC	-0.14	-0.06	+57.1%	1.46	+3.4%	-6.2%	+1.5%	-5.0%	+6.1%	-2.1%	—
Feb 19, 2025	AMC	-0.06	-0.06	+0.0%	1.97	-4.1%	-9.6%	+2.8%	-3.8%	-1.1%	-4.6%	—
Nov 13, 2024	AMC	-0.06	-0.06	+0.0%	2.00	+4.5%	-8.5%	+0.0%	-1.6%	+5.6%	+2.6%	—
Aug 8, 2024	AMC	-0.06	-0.05	+16.7%	1.15	+0.9%	+0.9%	-2.6%	+0.0%	+0.9%	+1.8%	—
May 9, 2024	AMC	-0.05	-0.06	-20.0%	1.46	+1.4%	+4.8%	-0.7%	-2.6%	+0.7%	-4.0%	—
Feb 15, 2024	AMC	-0.08	-0.04	+50.0%	1.35	+0.7%	+0.7%	+0.7%	-1.5%	-1.5%	-3.8%	—
Nov 9, 2023	AMC	-0.08	-0.01	+87.5%	1.79	+2.5%	-0.6%	+0.8%	-3.1%	+1.1%	+0.0%	—
Aug 9, 2023	AMC	-0.07	-0.06	+14.3%	2.36	+0.8%	+1.7%	+0.2%	-1.0%	-2.9%	+6.9%	—
May 11, 2023	AMC	-0.07	-0.06	+14.3%	2.16	+3.7%	+0.0%	+2.1%	-0.7%	+0.9%	-4.1%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Jan 30	D. Boral Capital	Maintains	Buy → Buy	—	$1.75	$1.83	+4.6%	-1.7%	-3.5%	-1.2%	-0.6%	-0.6%
Dec 18	D. Boral Capital	Maintains	Buy → Buy	—	$1.47	$1.49	+1.4%	-1.4%	-1.4%	-2.8%	-5.0%	-3.0%
Dec 8	D. Boral Capital	Maintains	Buy → Buy	—	$1.56	$1.58	+1.3%	-3.2%	+2.0%	-1.9%	+0.0%	+2.0%
Nov 4	D. Boral Capital	Maintains	Buy → Buy	—	$1.50	$1.43	-4.7%	-5.3%	+6.3%	-7.3%	+1.4%	-0.7%
Oct 31	D. Boral Capital	Maintains	Buy → Buy	—	$1.19	$1.36	+14.3%	+39.5%	-9.6%	-5.3%	+6.3%	-7.3%
Sep 22	D. Boral Capital	Maintains	Buy → Buy	—	$1.27	$1.29	+1.6%	+0.8%	-0.8%	-1.6%	-0.8%	+2.4%
Aug 27	D. Boral Capital	Maintains	Buy → Buy	—	$1.36	$1.43	+5.1%	-1.5%	+0.0%	-2.2%	+0.0%	+0.8%
Jul 24	D. Boral Capital	Maintains	Buy → Buy	—	$1.26	$1.25	-0.8%	-1.6%	+17.7%	-0.7%	-8.3%	+1.5%
Jun 16	B. Riley Securities	Maintains	Buy → Buy	—	$1.33	$1.32	-0.8%	+0.0%	-5.3%	+0.8%	+1.6%	+1.6%
Apr 9	D. Boral Capital	Maintains	Buy → Buy	—	$1.24	$1.26	+1.6%	+5.6%	-3.1%	+8.7%	+1.4%	+0.0%
Mar 14	D. Boral Capital	Maintains	Buy → Buy	—	$1.47	$1.51	+2.7%	+5.4%	-0.6%	-2.6%	+3.3%	-2.6%
Feb 21	D. Boral Capital	Maintains	Buy → Buy	—	$1.78	$1.80	+1.1%	+2.8%	-3.8%	-1.1%	-4.6%	+1.2%
Dec 6	D. Boral Capital	Maintains	Buy → Buy	—	$2.26	$2.33	+3.1%	+3.5%	-1.7%	-1.7%	-4.0%	-1.4%
Mar 13	B. Riley FBR	Maintains	Buy → Buy	—	$3.13	$3.47	+10.9%	+28.8%	-2.5%	+5.6%	-21.0%	+5.2%
Mar 13	B. Riley Securities	Maintains	Buy → Buy	—	$3.13	$3.47	+10.9%	+28.8%	-2.5%	+5.6%	-21.0%	+5.2%
May 24	Ladenburg Thalmann	Maintains	Buy → Buy	—	$2.75	$1.29	-53.1%	-42.9%	+11.5%	-0.4%	-0.7%	+1.2%

Data updated apr 26, 2026 12:47pm · Source: massive.com